More tools:
Markets
·
Screener
·
Research
·
Chat
CONEXEU SCIENCES INC (CNXU) Financial Statements
CONEXEU SCIENCES INC
SIC 3842 · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
FIGI BBG0200TPK10
US
4.75
▼ 8.53 (-64.23%)
As of 2026-09-08
1M
6M
1Y
Valuation
Market Cap
$127.1M
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
13.28
Day's Range
12.05 – 13.50
52-Week Range
9.60 – 18.79
Volume
36.3K
Avg Volume
90.0K
Share Statistics
Shares Outstanding
26.8M
Employees
—
Exchange
US
Listed
—
Share count as of June 10, 2026
View
Income Statement
Balance Sheet
Cash Flow
Key Metrics
Valuation
Comparable Companies
Notes & Facts
DCF Model
Earnings Calls
Guidance
Presentations
Detail
Standard
Detailed
Period
Annual
Quarterly
TTM
Loading Income Statement…
Key questions about CONEXEU SCIENCES INC (CNXU)
What is CONEXEU SCIENCES INC's Market Cap?
CONEXEU SCIENCES INC's Market Cap is $127.1M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Subscribe
Income Statement
(in thousands of USD, except per-share data)
Source: Akyla.ai
Line Item
Apr 30, 2026
Apr 30, 2025
OPERATING EXPENSES
Advertising and promotion
9.3
Depreciation and amortization
11.4
Bank charges
3.6
Business development
85.7
Consulting
1,228.9
Filing fees
17.6
Insurance
4.1
Investor relations
1.1
Management and directors' salaries and fees - related parties
609.6
Office and general administrative
16.9
Professional fees
325.5
Research and development
66.6
Total operating expenses
2,380.4
LOSS FROM OPERATIONS
(2,380.4)
OTHER INCOME (EXPENSES)
Gain on conversion of payables
0.0
Interest income
84.3
Interest expense
0.0
Foreign exchange gain (loss)
(8.2)
Total other income (expenses)
76.1
LOSS BEFORE TAXES
(2,304.3)
Income tax benefit (expense)
0.0
NET LOSS
(2,304.3)
Net loss per common share, basic
(0.11)
Net loss per common share, diluted
(0.11)